Inhibition of tumor-specific angiogenesis by AS1411 aptamer functionalized Withaferin A loaded PEGylated nanoliposomes by targeting nucleolin
- 25 May 2023
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 673, 106-113
Abstract
No abstract availableKeywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India
This publication has 28 references indexed in Scilit:
- Dimethylfumarate Inhibits Angiogenesis In Vitro and In Vivo: A Possible Role for Its Antipsoriatic Effect?Journal of Investigative Dermatology, 2011
- Soluble PTK7 inhibits tube formation, migration, and invasion of endothelial cells and angiogenesisBiochemical and Biophysical Research Communications, 2008
- Suppression of Tumor Growth and Angiogenesis by a Specific Antagonist of the Cell-Surface Expressed NucleolinPLOS ONE, 2008
- Amentoflavone Inhibits Experimental Tumor Metastasis Through a Regulatory Mechanism Involving MMP-2, MMP-9, Prolyl Hydroxylase, Lysyl Oxidase, VEGF, ERK-1, ERK-2, STAT-1, nm23 and Cytokines in Lung Tissues of C57BL/6 MiceImmunopharmacology and Immunotoxicology, 2008
- β-Carotene Inhibits Tumor-Specific Angiogenesis by Altering the Cytokine Profile and Inhibits the Nuclear Translocation of Transcription Factors in B16F-10 Melanoma CellsIntegrative Cancer Therapies, 2007
- Angiogenesis in cancerVascular Health and Risk Management, 2006
- Vascular Endothelial Growth Factor and AngiogenesisPharmacological Reviews, 2004
- Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vesselsJournal of Cell Biology, 2003
- Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1‐MMP, MMP‐2 and MMP‐9 in human glioblastomasInternational Journal of Cancer, 2003
- ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESISJournal of Experimental Medicine, 1971